Internal Medicine, Infectious Disease · Palm Springs, CA
NPI
1851477582
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
4791 E Palm Canyon Dr Ste 100
Palm Springs, CA, 92264
Phone (760) 834-7930
Groups this clinician bills Medicare through
Medicare paid, 2024
$62K
921 services
Medicare patients, 2024
315
Average age 73
Drug cost, 2024
$12.3M
9,673 prescriptions
Company payments, 2024
$150
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ann E Stapleton was code 99214 (office e&m - established), 552 times for 227 patients. In total Ann E Stapleton billed 921 services in 22 codes, and Medicare paid $62K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-01-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 552 | 227 | $70.23 | $39K |
| 99232 Hospital E&M - Subsequent | Facility | 94 | 54 | $62.94 | $5,916 |
| 99213 Office E&M - Established | Office | 66 | 49 | $50.38 | $3,325 |
| 99443 Telephone Services | Office | 60 | 44 | $70.78 | $4,247 |
| 99222 Hospital E&M - Initial | Facility | 34 | 34 | $104.45 | $3,551 |
| 99231 Hospital E&M - Subsequent | Facility | 29 | 20 | $39.54 | $1,147 |
| 99442 Telephone Services | Office | 27 | 27 | $51.07 | $1,379 |
| 99221 Hospital E&M - Initial | Facility | 16 | 16 | $57.34 | $918 |
By year: 2022 $58K for 1,018 services; 2023 $71K for 1,002 services; 2024 $62K for 921 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ann E Stapleton prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 809 prescriptions and refills. In total Ann E Stapleton wrote 9,673 Medicare prescriptions that cost $12.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 809 | 873 | 91 | $3.5M |
| Atorvastatin Calcium Generic | 504 | 1,222 | 126 | $4,620 |
| Tivicay Dolutegravir Sodium | 382 | 394 | 45 | $987K |
| Descovy Emtricitabine/Tenofov Alafenam | 262 | 280 | 34 | $641K |
| Rosuvastatin Calcium Generic | 248 | 623 | 83 | $3,993 |
| Lisinopril Generic | 229 | 532 | 61 | $1,792 |
| Testosterone Generic | 226 | 285 | 54 | $31K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 195 | 215 | 25 | $844K |
| Prezcobix Darunavir/Cobicistat | 194 | 194 | 21 | $495K |
| Juluca Dolutegravir/Rilpivirine | 189 | 219 | 23 | $801K |
| Alprazolam Generic | 170 | 206 | 30 | $1,436 |
| Testosterone Cypionate Generic | 162 | 212 | 38 | $6,032 |
| Zolpidem Tartrate Generic | 153 | 195 | 38 | $1,341 |
| Tamsulosin Hcl Generic | 152 | 343 | 40 | $2,180 |
| Pifeltro Doravirine | 151 | 181 | 17 | $328K |
Brand drugs: 3,464 claims; generic drugs: 6,195 claims; opioid claims: 197.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Ann E Stapleton $150 ($150 in general payments such as food, travel and fees) from 1 company. The largest payer was Gilead Sciences, Inc. with $150.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 1 | $150 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.